IL319591A - Cyclic peptide derivative composition for treating or preventing eye diseases - Google Patents

Cyclic peptide derivative composition for treating or preventing eye diseases

Info

Publication number
IL319591A
IL319591A IL319591A IL31959125A IL319591A IL 319591 A IL319591 A IL 319591A IL 319591 A IL319591 A IL 319591A IL 31959125 A IL31959125 A IL 31959125A IL 319591 A IL319591 A IL 319591A
Authority
IL
Israel
Prior art keywords
treating
cyclic peptide
eye disease
peptide derivative
derivative composition
Prior art date
Application number
IL319591A
Other languages
English (en)
Hebrew (he)
Inventor
Kohei Matsumoto
Kaito Onishi
Kana Teragami
Yuma Karita
Shichidai TANABE
Kosuke Yasui
Takeshi Shosu
Original Assignee
Dks Co Ltd
Kohei Matsumoto
Kaito Onishi
Kana Teragami
Yuma Karita
Shichidai TANABE
Kosuke Yasui
Takeshi Shosu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dks Co Ltd, Kohei Matsumoto, Kaito Onishi, Kana Teragami, Yuma Karita, Shichidai TANABE, Kosuke Yasui, Takeshi Shosu filed Critical Dks Co Ltd
Publication of IL319591A publication Critical patent/IL319591A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL319591A 2022-09-30 2023-09-29 Cyclic peptide derivative composition for treating or preventing eye diseases IL319591A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022159075 2022-09-30
PCT/JP2023/035591 WO2024071370A1 (ja) 2022-09-30 2023-09-29 眼科疾患を処置または予防するための環状ペプチド誘導体組成物

Publications (1)

Publication Number Publication Date
IL319591A true IL319591A (en) 2025-05-01

Family

ID=90478092

Family Applications (1)

Application Number Title Priority Date Filing Date
IL319591A IL319591A (en) 2022-09-30 2023-09-29 Cyclic peptide derivative composition for treating or preventing eye diseases

Country Status (8)

Country Link
US (1) US20260091082A1 (https=)
EP (1) EP4595973A1 (https=)
JP (1) JPWO2024071370A1 (https=)
KR (1) KR20250077478A (https=)
CN (1) CN119947740A (https=)
IL (1) IL319591A (https=)
TW (1) TW202430203A (https=)
WO (1) WO2024071370A1 (https=)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
DE69839355T2 (de) 1997-07-29 2009-06-04 Alcon Laboratories, Inc., Fort Worth Ophthalmische Zusammensetzungen enthaltend Galaktomannanpolymere und Borat
AU2483599A (en) 1998-01-29 1999-08-16 Sepracor, Inc. Pharmaceutical uses of optically pure (-)-bupropion
US8889112B2 (en) 1999-09-16 2014-11-18 Ocularis Pharma, Llc Ophthalmic formulations including selective alpha 1 antagonists
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
EP1654002B2 (en) 2003-08-07 2014-01-29 Allergan, Inc. Compositions for delivery of therapeutics into the eyes
US20050059744A1 (en) 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
WO2016047638A1 (ja) * 2014-09-24 2016-03-31 国立大学法人岩手大学 環状ペプチド誘導体とその製造方法および組成物
JP7486328B2 (ja) * 2020-03-05 2024-05-17 株式会社バイオコクーン研究所 神経突起伸長促進剤、神経細胞の樹状突起発現促進剤、及び神経栄養因子様作用物質
JP7695662B2 (ja) * 2020-11-02 2025-06-19 公立大学法人大阪 環状ペプチド誘導体の製造方法及び環状ペプチド化合物の製造方法

Also Published As

Publication number Publication date
WO2024071370A1 (ja) 2024-04-04
CN119947740A (zh) 2025-05-06
EP4595973A1 (en) 2025-08-06
KR20250077478A (ko) 2025-05-30
US20260091082A1 (en) 2026-04-02
TW202430203A (zh) 2024-08-01
JPWO2024071370A1 (https=) 2024-04-04

Similar Documents

Publication Publication Date Title
EP3954395A4 (en) Pharmaceutical composition for muscle disease treatment
PT3861985T (pt) Composições e métodos para tratar doenças oculares
BR112022007489A2 (pt) Forma amorfa de um receptor c5a de componente do complemento
IL273843A (en) Pharmaceutical compositions for the treatment of the corona virus disease covid-19
IL308628A (en) Methods for treating type 1 diabetes
IL304273A (en) Compositions and methods for treating Fabry disease
IL304771A (en) Preparations and methods for the treatment of a disease associated with dux4 overexpression
IL317947A (en) Complementary disease treatment methods
ZA202107235B (en) Compositions and methods for treating ocular disease
EP4341382A4 (en) COMPOSITIONS AND METHODS FOR TREATING DISEASES
EP3831365A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF ATOPIC DISEASES
IL319591A (en) Cyclic peptide derivative composition for treating or preventing eye diseases
EP3785715A4 (en) Pharmaceutical composition comprising ibrutinib as effective ingredient for preventing or treating degenerative brain disease
KR102587729B9 (ko) 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물
EP3927375A4 (en) COMPOSITIONS FOR THE TREATMENT OF DISEASES
CA3267775A1 (en) Cyclic peptide derivative composition for treating or preventing eye disease
KR102467285B9 (ko) 우황청심환을 포함하는 파킨슨 질환 예방 또는 치료용 약학 조성물
EA202193211A1 (ru) Лечение синуклеопатий
EP4353226A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF DEGENERATIVE EYE DISEASES
KR102276379B9 (ko) IF1 (ATPase inhibitory factor 1)을 유효성분으로 함유하는 골질환의 예방 또는 치료용 약학 조성물
IL315594A (en) SNCA-targeted siRNA constructs for the treatment of SNCA-related diseases
CA3272164A1 (en) Cyclic peptide derivative composition for treating or preventing central nervous system injury/disease
KR102526197B9 (ko) Cotl1을 유효성분으로 포함하는 골질환 진단, 예방 또는 치료용 조성물
IL290351A (en) Compositions and methods for the treatment of neurological diseases
MX2022003598A (es) Composicion farmaceutica, que comprende la proteina galectina 9 recombinante estabilizada, para la prevencion o el tratamiento de la artritis reumatoide y enfermedades oseas.